167 related articles for article (PubMed ID: 25003569)
1. Maintenance therapy in metastatic colorectal cancer.
Marshall JL
Clin Adv Hematol Oncol; 2014 Jun; 12(6):388-90. PubMed ID: 25003569
[No Abstract] [Full Text] [Related]
2. [First-line chemotherapy for unresectable and metastatic colorectal cancer].
Satoh T
Gan To Kagaku Ryoho; 2014 Nov; 41(11):1372-5. PubMed ID: 25577805
[No Abstract] [Full Text] [Related]
3. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
[No Abstract] [Full Text] [Related]
4. Targeted therapy for colorectal cancer resistance to EGF receptor antibodies and new trends.
Katsios C; Ziogas DE; Roukos DH; Baltogiannis G
Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):5-8. PubMed ID: 23265143
[No Abstract] [Full Text] [Related]
5. [Use of maintenance therapy and complete discontinuation for therapeutic management of non-resectable metastatic colorectal cancer].
Senellart H; Hiret S; Guerin-Meyer V; Bennouna J
Bull Cancer; 2014 Jun; 101(6):619-25. PubMed ID: 24977450
[TBL] [Abstract][Full Text] [Related]
6. Integration of anti-epidermal growth factor receptor therapies with cytotoxic chemotherapy.
Serrano C; Markman B; Tabernero J
Cancer J; 2010; 16(3):226-34. PubMed ID: 20526101
[TBL] [Abstract][Full Text] [Related]
7. Dual blockade of epidermal growth factor receptor-induced pathways: a new avenue to treat metastatic colorectal cancer.
Laurent-Puig P; Manceau G; Zucman-Rossi J; Blons H
J Clin Oncol; 2012 May; 30(13):1550-2. PubMed ID: 22412137
[No Abstract] [Full Text] [Related]
8. Metastatic colorectal cancer.
Saletti P; Cavalli F
Cancer Treat Rev; 2006 Nov; 32(7):557-71. PubMed ID: 16935430
[TBL] [Abstract][Full Text] [Related]
9. Testing for RAS mutations in patients with metastatic colorectal cancer.
Lenz HJ
Clin Adv Hematol Oncol; 2014 Jan; 12(1):48-9. PubMed ID: 25000315
[No Abstract] [Full Text] [Related]
10. Epidermal growth factor receptor inhibitors and colorectal cancer.
Meyerhardt JA; Fuchs CS
Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):35-8. PubMed ID: 15685832
[TBL] [Abstract][Full Text] [Related]
11. First-line treatment options for patients with metastatic colorectal cancer.
Schilsky RL
Nat Clin Pract Oncol; 2004 Dec; 1(2):70-1. PubMed ID: 16264820
[No Abstract] [Full Text] [Related]
12. First-line treatment of patients with metastatic colorectal cancer: an overview of recent data on chemotherapy plus targeted agents.
Cercek A; Saltz LB
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S47-51. PubMed ID: 19064406
[TBL] [Abstract][Full Text] [Related]
13. Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?
Nipp RD; Ryan DP
Oncologist; 2015 Mar; 20(3):236-8. PubMed ID: 25660156
[TBL] [Abstract][Full Text] [Related]
14. Prolonged survival of patients with metastatic colorectal cancer following first-line oxaliplatin-based chemotherapy with molecular targeting agents and curative surgery.
Shitara K; Matsuo K; Kondo C; Takahari D; Ura T; Inaba Y; Yamaura H; Sato Y; Kato M; Kanemitsu Y; Komori K; Ishiguro S; Sano T; Shimizu Y; Muro K
Oncology; 2011; 81(3-4):167-74. PubMed ID: 22057124
[TBL] [Abstract][Full Text] [Related]
15. Controversies in antiepidermal growth factor receptor therapy in metastatic colorectal cancer.
Woo J; Palmisiano N; Tester W; Leighton JC
Cancer; 2013 Jun; 119(11):1941-50. PubMed ID: 23504768
[TBL] [Abstract][Full Text] [Related]
16. Emerging phase 3 data in relapsed/refractory metastatic colorectal cancer.
Goldberg R
Clin Adv Hematol Oncol; 2016 Jan; 14(1):30-3. PubMed ID: 27057664
[No Abstract] [Full Text] [Related]
17. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
Cassidy J
Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
[No Abstract] [Full Text] [Related]
18. Epidermal growth factor receptor: pathway, therapies, and pipeline.
Goffin JR; Zbuk K
Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
[TBL] [Abstract][Full Text] [Related]
19. Cetuximab in the treatment of colorectal cancer.
Goldberg RM; Venook AP; Schilsky RL
Clin Adv Hematol Oncol; 2004 Nov; 2(11):1-10; quiz 11-12. PubMed ID: 16170891
[No Abstract] [Full Text] [Related]
20. Clinical predictive factors.
Köhne CH; Vanhoefer U; Hartung G
Eur J Cancer; 2009 Sep; 45 Suppl 1():43-9. PubMed ID: 19775603
[No Abstract] [Full Text] [Related]
[Next] [New Search]
